EyeCon 2026 Banner

News

The Intelligent Research in Sight (IRIS) Registry-a comprehensive eye disease registry developed by the American Academy of Ophthalmology (AAO)-has far surpassed early estimates for physician participation, according to William L. Rich III, MD, FACS.

When considering the Boston type 1 keratoprosthesis as the evidence-based procedure of choice for managing cornea graft failure, superior visual outcomes must be weighed against greater risk of sight-threatening complications.

Ophthalmology Times is pleased to announce Igor I. Bussel, MD, MS, MHA, and Deepinder K. Dhaliwal, MD (faculty sponsor), of the Department of Ophthalmology, University of Pittsburgh/UPMC Eye Center, Pittsburgh, as the second-place winner of the 2017 Resident Writer’s Award Program, sponsored by Allergan. Their entry is featured here.

Dr. Francesco Oddone, Head of the Glaucoma Research Unit at Bietti Foundation, Rome, speaks about the most interesting features of COMPASS, the unique automatic perimeter combined with a scanning ophthalmoscope, able to provide retinal threshold sensitivity as well as confocal images of the retina.

David Lin, MD, Medical Director Pacific Laser Eye Centre in Vancouver, Canada, shares his experiences with SCHWIND SmartSurfACE treatment and how this procedure completely transformed the way of the clinic performing laser surgery.

The doctor’s doctor

A few months into my residency, a patient and her husband came to see me in clinic. The history revealed they had already sought the opinions of two internationally acknowledged giants in the field of retinal disease, one of whom was a department chairman. The answers they received on those visits had differed somewhat, so they were now coming to get the tie-breaking third opinion. “Thank goodness they have no idea I am just a first-year resident,” I thought to myself.

Many new diagnostic tools are available for dry eye and ocular surface disease (OSD). Treatments for dry eye and OSD have mixed results, however, said Bennie H. Jeng, MD.